Keyword: cancer drugs

News

Roche Takes $1.7 Billion Charges as it Confirms Outlook

26.07.2012 - Swiss drugmaker Roche Holding took $1.7 billion in restructuring charges it said should lead to big savings as it confirmed its outlook on Thursday with first-half sales beating...

News

China Changes Patent Law in Fight for Cheaper Drugs

09.06.2012 - China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap copies of medicines still under patent protection in an initiative likely to...

News

Merck KGaA, Dr. Reddy's in Biosimilars Deal

06.06.2012 - Germany's Merck KGaA and India's Dr. Reddy's Laboratories have struck a deal to develop cheap versions of biotech cancer drugs, seeking to tap into a new market as patents on...

News

Roche Q1 Sales Flat as Illumina Bid Battle Rages

12.04.2012 - Swiss drugmaker Roche dangled the prospect of a higher offer before reluctant U.S. bid target Illumina on Thursday along with broadly flat first-quarter sales supported by its top...

News

Chasing Cheaper Cancer Drugs

02.04.2012 - In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research...

News

Roche Extends Illumina Bid Again

26.03.2012 - Roche extended its $5.7 billion cash bid for U.S. gene decoder Illumina for a second time as the Swiss drugmaker sticks to its tried and tested M&A strategy of playing a long game...